1Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease [J]. Am Soc Nephrol, 2006, 17( 11 ) : 2992-2998.
2Liu Y. Renal fibrosis: new insights into the pathogenesisand therapeutics [ J ]. Kidney Int, 2006,69 ( 2 ) : 213-217.
3Eddy A A. Molecular basis of renal fibrosis [J]. Pediatr Nephrol, 2000, 15(3-4) : 290-301.
4Seccia T M, Maniero C, Belloni A S,et al. Role of angiotensin Ⅱ , endothelin-1 and L-type calcium channel in the development of glomerular, tubulointerstitial and perivascular fibrosis [J]. J Hypertens, 2008, 26(10):2022-2029.
5Tan A L, Fordes J M, Cooper M E. AGE, RACE, and Ros in diabetic nephropathy [ J ]. Semin Nephrol , 2007,27 ( 2 ) : 130-143.
8Forine M, Torregrossa R, Ced M, et al. TGF-beta1 induce epithelail mesenchymal transition but not myofibroblast transdifferentiation of human kidney tubular epithelial cell in primary allture [J]. Int J Exp Pathol, 2006,87 (3) : 197-208.
9Qi W, Chen X, Poronnik P, et al. Transforming growth factor-beta/ connective tissue growth factor axis in the kidney [J ]. Int J Bioehem Cell Biol, 2008,40(1):9-13.
10Oliver G, Eckhard S, Marie-Louise K, et al. Antifibrotic, nephroprotee-tive potential of ACE inhibitor vsAT1 antagonist in a murine model of renal fibrosis [J]. Nephrol Dial Transplant, 2004, 19(7) .: 1716-1723.
